Allison is Associate Editorial Director for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®. She joined AJMC® in 2017. She produces and oversees written, video, and podcast content across several disease states and issues surrounding value-based care and health policy.
She has an MPA from New York University. You can connect with Allison on LinkedIn.
Clinicians Hear More Questions as Patient Awareness of Oncology Genetic Testing Grows
October 24th 2019With increasing awareness of genetic testing and advancements in precision medicine, more patients are seeking counsel from clinicians about what steps they should take if mutations are found. This requires physicians to become more informed, and a recent article discusses the hypothetical case of an Ashkenazi Jewish woman with breast cancer.
While Waiting for ACA Decision, HHS Says 2020 Benchmark Plan Premiums Mostly Lower
October 22nd 2019HHS Secretary Alex Azar said his messaging about the Affordable Care Act (ACA) will be simple if the federal 5th Circuit Court of Appeals, in a decision that is expected any day now, sides with the administration in Texas vs Azar in finding the 2010 landmark health law unconstitutional. “Keep calm and carry on,” he said, as he and CMS Administrator Seema Verma released information about 2020 ACA premiums and health plan choices.
Novel Drugs for MM Take Longer to Reach Black, Hispanic Patients Than White Patients
October 17th 2019The study found that, on average, it took nearly 2 months or longer for patients of color to receive immunomodulatory drugs such as lenalidomide and/or proteasome inhibitors such as bortezomib and carfilzomib. The use of these therapies has more than doubled survival of patients with multiple myeloma within the past decade.
Tesamorelin Shows Effectiveness at Fighting NAFLD in Patients With HIV
October 16th 2019As a result of the study, investigators suggested expanding the indication for tesamorelin (Egrifta) to include people living with HIV who have been diagnosed with nonalcoholic fatty liver disease (NAFLD), a comorbidity in HIV.
Severe Psoriasis Linked to Higher Risk of Death From Liver, Esophageal, Pancreatic Cancers
October 16th 2019Patients with severe psoriasis have an increased risk of dying from liver, esophageal, and pancreatic cancers, and people with psoriasis have an overall increased risk of a variety of other cancers, according to a meta-analysis and review published Wednesday in JAMA Dermatology.
MBC Treatment Not Aligned With NCCN Guidelines Leads to Higher Patient Cost Responsibility
October 15th 2019Patients on Medicare with metastatic breast cancer who receive treatment that is discordant with NCCN guidelines bear a greater burden of patient cost responsibility than patients who do receive care according to treatment guidelines.
Quality of Life Declines for Patients With Relapsed or Refractory MM Before Progression Appears
October 12th 2019Declines in global health status and quality of life, physical functioning, fatigue, and pain begin to appear 2 to 3 months before progression of the underlying malignant disease, multiple myeloma researchers said in a new study.
Higher BMI Appears to Have Protective Effect Against Dementia in Patients With PD
October 11th 2019A higher-than-normal body mass index (BMI) at the time of a diagnosis of Parkinson disease (PD) has a protective effect against cognitive decline and the conversion to dementia, a recent study indicated.
HHS Issues Guide to Reducing Long-term Opioid Use Without Harming Patients in Chronic Pain
October 11th 2019In an effort to educate clinicians about the issue of forcing patients in pain to suddenly halt opioid use, HHS released a guide that emphasizes patient-centered care and recommends against a rapid taper or stopping opioids all at once, while a patient living with chronic pain both welcomed the guide and expressed concern.
HHS Releases Proposal to Reform Stark Law, Antikickback Rules
October 9th 2019In a long-awaited move, HHS announced Tuesday plans to reform federal antikickback statutes and overhaul the so-called Stark Law, which was originally intended as a safeguard against financial incentives that would inappropriately influence physicians’ clinical decisions, in an effort to speed the transition to value-based care.
HHS Releases Proposal to Reform Stark Law, Antikickback Rules
October 9th 2019In a long-awaited move, HHS announced Tuesday plans to reform federal antikickback statutes and overhaul the so-called Stark Law, which was originally intended as a safeguard against financial incentives that would inappropriately influence physicians’ clinical decisions, in an effort to speed the transition to value-based care.
Journal Retracts, Republishes COPD Study After Authors Find Intervention Created Harm, Not Benefit
October 8th 2019JAMA on Tuesday retracted and republished a 2018 study about chronic obstructive pulmonary disease (COPD) after the discovery of a programming error in the statistical analysis. The subsequent complete reanalysis by the authors showed that the intervention that was studied showed harm, rather than benefit, to patients.
Patients With PD, Mild Cognitive Impairment See Benefit From Transcranial Magnetic Stimulation
October 7th 2019Noninvasive transcranial magnetic stimulation (TMS) may help improve cognitive performance in patients with Parkinson disease (PD) and mild cognitive impairment, according to a recent study.
GAO Report Finds ACA Helped Increase Coverage for American Indians, Alaskan Natives
October 2nd 2019The Government Accountability Office (GAO)’s analysis of Indian Health Service (IHS) data shows that from fiscal years 2013 through 2018, the percentage of patients at federally operated IHS hospitals and health centers who reported having health insurance coverage increased an average of 14 percentage points, from 64% in 2013 to 78% in 2018.
Elevated C-Reactive Protein Levels Linked With Migraines Occurring 15 Days or More, or With Aura
October 2nd 2019Researchers said the previous results on high sensitivity C-reactive protein and migraine are mixed, and the relationship to insomnia limited; the aim of this study was to evaluate the cross-sectional association between hs-CRP and types of headache, and to see whether the relationship to insomnia could be reproduced.
PwC Report Urges Action to Tackle Social Determinants of Health
September 26th 2019Governments and health systems can save money in the long term and improve health outcomes by investing earlier in social determinant of health strategies that help people with housing, exercise, mental health, as well as the ability to afford costly prescription drug medication, the report said.
Pilot Food as Medicine Program in Texas Shows Promise, Challenges
September 21st 2019Residents of North Pasadena, Texas, struggling with food insecurity obtained “prescriptions” for healthy food from their clinic providers and boosted their intake of fruits, vegetables, lean protein, beans, and whole grains, in another example of the food as medicine movement that also illustrates some of the challenges with these efforts.
Pelosi Unveils Bill to Lower Prescription Drug Prices
September 19th 2019House Speaker Nancy Pelosi unveiled her plan to lower drug prices by giving the government the ability to negotiate prices for up to 250 of the costliest drugs, including insulin; slapping pharmaceutical companies with penalties if they refuse to negotiate; and seeking Medicare rebates from drug makers if they raise prices beyond inflation.
Peanut OIT Study Gives Insights Into the Few Patients Who Might Benefit From Therapy
September 13th 2019As an FDA advisory committee prepares to meet Friday to discuss an application from Aimmune Therapeutics for AR101, its peanut oral immunotherapy (OIT) product, results of a different phase 2 study were released late Thursday indicating that those with allergies to the legume would have to continue treatment in order to avoid reactions.